Tomohito Ohtani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tomohito Ohtani has a total of 218 co-authors. Here are the top co-authors by number of shared publications:
- Yasushi Sakata
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
31 shared publications Yasushi Sakata
Department of Cardiovascular Medicine, The University of Osaka Graduate School of Medicine, Suita, Japan
21 shared publicationsKei Nakamoto
Department of Cardiology, Osaka Police Hospital, Osaka, Japan
15 shared publicationsYasumasa Tsukamoto
Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Japan
14 shared publicationsFusako Sera
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Osaka, Suita, Japan
12 shared publicationsMisato Chimura
Department of Cardiovascular Medicine Graduate School of Medicine The University of Osaka Suita Osaka Japan
12 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-9
Current diagnostic clinical examinations for cardiomyopathies: a nationwide survey of cardiologists in Japan
Idiopathic cardiomyopathies—including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC)—are diagnosed after excluding secondary cardiomyopathies caused by systemic diseases or specific etiologies. Although current guidelines recommend several diagnostic examinations to aid in this differentiation, the extent to which these tests are used in routine clinical practice and their associated factors remain unclear. We conducted a nationwide web-based questionnaire survey among physicians of the Japanese Circulation Society. An invitation was sent by email to 25,258 physicians, and responses were collected anonymously between January 10 and February 28, 2024. The questionnaire assessed respondents’ characteristics and whether they would perform diagnostic examinations for each cardiomyopathy using a five-point Likert scale. Responses were categorized into two groups (“always/frequently” vs. “sometimes/rarely/never”), and multivariable nominal logistic regression analysis was performed to examine associations between respondent characteristics and reported routine use of diagnostic tests. Adjusted trends were also assessed for clinical experience and hospital bed categories. Among 1103 (4.4%) respondents, the frequency of diagnostic examinations varied by cardiomyopathy type. A high proportion of respondents (95%) reported that they would perform coronary evaluations in DCM, whereas this proportion was approximately 80% for other idiopathic cardiomyopathies. In contrast, the proportion of respondents reporting frequent use of examinations relevant to the differential diagnosis of secondary cardiomyopathies, such as endomyocardial biopsy (EMB), cardiac magnetic resonance imaging (MRI), and nuclear imaging, was generally low. Multivariable analysis showed that institutional and physician-related factors were associated with reported testing patterns. Respondents working at larger hospitals more frequently reported routine use of most examinations, and those with fewer years of clinical experience more often reported that they would perform MRI in DCM and EMB and MRI in HCM. In addition, respondents reporting less frequent EMB use in DCM also reported less frequent use of MRI and 67 Ga scintigraphy/ 18 F-fluorodeoxyglucose positron emission tomography. In Japan, the proportion of physicians reporting that they would routinely perform several examinations relevant to the differential diagnosis of secondary cardiomyopathies was low, and these responses were associated with physician and institutional characteristics.
- 10 November 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-9
Open AccessCurrent diagnostic clinical examinations for cardiomyopathies: a nationwide survey of cardiologists in Japan
Idiopathic cardiomyopathies—including dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC)—are diagnosed after excluding secondary cardiomyopathies caused by systemic diseases or specific etiologies. Although current guidelines recommend several diagnostic examinations to aid in this differentiation, the extent to which these tests are used in routine clinical practice and their associated factors remain unclear. We conducted a nationwide web-based questionnaire survey among physicians of the Japanese Circulation Society. An invitation was sent by email to 25,258 physicians, and responses were collected anonymously between January 10 and February 28, 2024. The questionnaire assessed respondents’ characteristics and whether they would perform diagnostic examinations for each cardiomyopathy using a five-point Likert scale. Responses were categorized into two groups (“always/frequently” vs. “sometimes/rarely/never”), and multivariable nominal logistic regression analysis was performed to examine associations between respondent characteristics and reported routine use of diagnostic tests. Adjusted trends were also assessed for clinical experience and hospital bed categories. Among 1103 (4.4%) respondents, the frequency of diagnostic examinations varied by cardiomyopathy type. A high proportion of respondents (95%) reported that they would perform coronary evaluations in DCM, whereas this proportion was approximately 80% for other idiopathic cardiomyopathies. In contrast, the proportion of respondents reporting frequent use of examinations relevant to the differential diagnosis of secondary cardiomyopathies, such as endomyocardial biopsy (EMB), cardiac magnetic resonance imaging (MRI), and nuclear imaging, was generally low. Multivariable analysis showed that institutional and physician-related factors were associated with reported testing patterns. Respondents working at larger hospitals more frequently reported routine use of most examinations, and those with fewer years of clinical experience more often reported that they would perform MRI in DCM and EMB and MRI in HCM. In addition, respondents reporting less frequent EMB use in DCM also reported less frequent use of MRI and 67 Ga scintigraphy/ 18 F-fluorodeoxyglucose positron emission tomography. In Japan, the proportion of physicians reporting that they would routinely perform several examinations relevant to the differential diagnosis of secondary cardiomyopathies was low, and these responses were associated with physician and institutional characteristics.
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Association of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis
Background: In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy. Methods: We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction 99m Tc‐MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99m Tc‐MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO 2 ), with ≤60% defining impairment. Results: Seventy‐four patients (41%) had PPVO 2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO 2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow‐up of 807 days, 23 patients (13%) experienced the composite outcome of all‐cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO 2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO 2 of 60%, patients with high SRS and low PPVO 2 had the highest incidence of adverse events. Conclusions: Decreased myocardial 99m Tc‐MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99m Tc‐MIBI scintigraphy may provide prognostic information complementary to exercise capacity.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (17)
Open AccessAssociation of Summed Rest Score on Technetium‐99m Sestamibi With Exercise Capacity and Incident Adverse Outcomes in Hospitalized Patients With Nonischemic Cardiomyopathy: A Retrospective Analysis
Background: In nonischemic cardiomyopathy, the clinical relevance of decreased resting myocardial technetium‐99m sestamibi ( 99m Tc‐MIBI) uptake regarding exercise capacity and clinical outcomes remains incompletely understood. We investigated whether decreased 99m Tc‐MIBI uptake is associated with impaired exercise capacity and adverse clinical outcomes in nonischemic cardiomyopathy. Methods: We retrospectively analyzed 182 patients (mean age 51.4±14.0 years; 27% female) with nonischemic cardiomyopathy and left ventricular ejection fraction 99m Tc‐MIBI scintigraphy and cardiopulmonary exercise testing from 2016 to 2023. Myocardial uptake of 99m Tc‐MIBI was evaluated using the summed rest score (SRS). Exercise capacity was assessed by percentage of predicted peak oxygen consumption (PPVO 2 ), with ≤60% defining impairment. Results: Seventy‐four patients (41%) had PPVO 2 ≤60% and higher SRS (median: 12 versus 8; P < 0.001). Higher SRS remained significantly associated with PPVO 2 ≤60% after adjustment for relevant clinical covariates, including brain natriuretic peptide level, left ventricular ejection fraction, and heart failure duration. Over a median follow‐up of 807 days, 23 patients (13%) experienced the composite outcome of all‐cause death, ventricular assist device implantation, or heart transplantation. Higher SRS was associated with composite outcomes after adjusting for PPVO 2 ≤60%. Among the 4 groups stratified by median SRS of 9 and PPVO 2 of 60%, patients with high SRS and low PPVO 2 had the highest incidence of adverse events. Conclusions: Decreased myocardial 99m Tc‐MIBI uptake was associated with impaired exercise capacity and adverse outcomes in patients with nonischemic cardiomyopathy. Our findings suggest that myocardial injury assessment using 99m Tc‐MIBI scintigraphy may provide prognostic information complementary to exercise capacity.
- Open Access
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Cardiac Magnetic Resonance–Derived Parametric Mapping Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy
Background: We investigated whether radiomic scores (RadScores), computed from high‐dimensional quantitative features extracted from cardiac magnetic resonance parametric mapping images, can predict left ventricular reverse remodeling (LVRR) in patients with nonischemic dilated cardiomyopathy. Methods: This retrospective analysis included 74 patients with nonischemic dilated cardiomyopathy who received optimized medical therapy and underwent cardiac magnetic resonance. LVRR was defined as a left ventricular ejection fraction ≥40% with ≥10% increase at least 180 days after cardiac magnetic resonance. RadScores were calculated for each case as linear combinations of selected radiomic features, with coefficients derived from least absolute shrinkage and selection operator–penalized logistic regression on native longitudinal relaxation time (T1) and extracellular volume (ECV) fraction maps. Predictive performance for LVRR was evaluated using logistic regression and receiver operating characteristic analyses. Results: Patients with LVRR (n=31, 42%) had higher T1‐RadScore (0.72±1.52 versus −1.54±2.66; P P =0.005), lower mean‐ECV (31.5%±3.8% versus 34.9%±6.0%; P =0.004), and lower extent of late gadolinium enhancement (0.19±0.58 versus 2.99±6.5; P =0.047) than those without LVRR. The area under the receiver operating characteristic curve for predicting LVRR was 0.834 (95% CI, 0.716–0.909) for the T1‐RadScore and 0.718 (95% CI, 0.573–0.827) for the ECV‐RadScore. Adding T1‐ and ECV‐RadScore combination to the extent of late gadolinium enhancement model significantly improved the area under the receiver operating characteristic curve from 0.618 to 0.903 ( P <0.0001). Conclusions: Radiomic scores extracted from native T1 and ECV maps may enhance LVRR prediction and provide incremental value beyond traditional late gadolinium enhancement assessment in patients with dilated cardiomyopathy.
- 4 August 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (15)
Open AccessCardiac Magnetic Resonance–Derived Parametric Mapping Radiomics for Prediction of Left Ventricular Reverse Remodeling in Patients With Dilated Cardiomyopathy
Background: We investigated whether radiomic scores (RadScores), computed from high‐dimensional quantitative features extracted from cardiac magnetic resonance parametric mapping images, can predict left ventricular reverse remodeling (LVRR) in patients with nonischemic dilated cardiomyopathy. Methods: This retrospective analysis included 74 patients with nonischemic dilated cardiomyopathy who received optimized medical therapy and underwent cardiac magnetic resonance. LVRR was defined as a left ventricular ejection fraction ≥40% with ≥10% increase at least 180 days after cardiac magnetic resonance. RadScores were calculated for each case as linear combinations of selected radiomic features, with coefficients derived from least absolute shrinkage and selection operator–penalized logistic regression on native longitudinal relaxation time (T1) and extracellular volume (ECV) fraction maps. Predictive performance for LVRR was evaluated using logistic regression and receiver operating characteristic analyses. Results: Patients with LVRR (n=31, 42%) had higher T1‐RadScore (0.72±1.52 versus −1.54±2.66; P P =0.005), lower mean‐ECV (31.5%±3.8% versus 34.9%±6.0%; P =0.004), and lower extent of late gadolinium enhancement (0.19±0.58 versus 2.99±6.5; P =0.047) than those without LVRR. The area under the receiver operating characteristic curve for predicting LVRR was 0.834 (95% CI, 0.716–0.909) for the T1‐RadScore and 0.718 (95% CI, 0.573–0.827) for the ECV‐RadScore. Adding T1‐ and ECV‐RadScore combination to the extent of late gadolinium enhancement model significantly improved the area under the receiver operating characteristic curve from 0.618 to 0.903 ( P <0.0001). Conclusions: Radiomic scores extracted from native T1 and ECV maps may enhance LVRR prediction and provide incremental value beyond traditional late gadolinium enhancement assessment in patients with dilated cardiomyopathy.
- 15 June 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-9
Coronary intimal proliferation despite lipid reduction during the first year after heart transplantation
Cardiac allograft vasculopathy (CAV) is a major cause of mortality after heart transplantation, characterized by intimal proliferation-induced coronary stenosis. The first year post-transplantation represents a critical period for CAV development, with most intimal proliferation occurring during this timeframe. This study aimed to investigate the temporal changes in lipid content and its relationship with intimal proliferation during the first year after heart transplantation. Serial three-vessel near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) and optical coherence tomography (OCT) were performed in 15 heart transplant recipients (38 coronary arteries) at 2 months (baseline) and 12 months (follow-up) following heart transplantation. From baseline to follow-up, the highest lipid-core burden index within a 4 mm segment (maxLCBI4mm) significantly decreased (median: 78.0 [IQR: 6.75 to 196] to 27.5 [IQR: 0 to 122], p = 0.008), while %intimal volume (intimal volume/vessel volume × 100) increased (median: 16.2% [IQR: 15.3 to 17.5] to 18.3% [IQR: 15.3 to 20.1], p = 0.006). Receiver operating characteristics (ROC) analysis identified a maxLCBI4mm cut-off of 124 for detecting OCT-assessed fibroatheroma (area under the ROC curve: 0.942, p < 0.001). In vessels with donor-transmitted fibroatheroma (maxLCBI4mm ≥ 124 at baseline), higher baseline maxLCBI4mm correlated with both more significant subsequent reduction in maxLCBI4mm (r2 = 0.482, p = 0.003) and more extensive intimal volume proliferation (r2 = 0.321, p = 0.022). Coronary artery lipid content generally decreased during the first year after heart transplantation. In vessels with donor-transmitted fibroatheroma, higher baseline lipid burden correlated with substantial lipid reduction and subsequent intimal volume proliferation.
- 15 June 2026
- Published by Springer Nature in Heart and Vessels
- p. 1-9
Coronary intimal proliferation despite lipid reduction during the first year after heart transplantation
Cardiac allograft vasculopathy (CAV) is a major cause of mortality after heart transplantation, characterized by intimal proliferation-induced coronary stenosis. The first year post-transplantation represents a critical period for CAV development, with most intimal proliferation occurring during this timeframe. This study aimed to investigate the temporal changes in lipid content and its relationship with intimal proliferation during the first year after heart transplantation. Serial three-vessel near-infrared spectroscopy intravascular ultrasound (NIRS-IVUS) and optical coherence tomography (OCT) were performed in 15 heart transplant recipients (38 coronary arteries) at 2 months (baseline) and 12 months (follow-up) following heart transplantation. From baseline to follow-up, the highest lipid-core burden index within a 4 mm segment (maxLCBI4mm) significantly decreased (median: 78.0 [IQR: 6.75 to 196] to 27.5 [IQR: 0 to 122], p = 0.008), while %intimal volume (intimal volume/vessel volume × 100) increased (median: 16.2% [IQR: 15.3 to 17.5] to 18.3% [IQR: 15.3 to 20.1], p = 0.006). Receiver operating characteristics (ROC) analysis identified a maxLCBI4mm cut-off of 124 for detecting OCT-assessed fibroatheroma (area under the ROC curve: 0.942, p < 0.001). In vessels with donor-transmitted fibroatheroma (maxLCBI4mm ≥ 124 at baseline), higher baseline maxLCBI4mm correlated with both more significant subsequent reduction in maxLCBI4mm (r2 = 0.482, p = 0.003) and more extensive intimal volume proliferation (r2 = 0.321, p = 0.022). Coronary artery lipid content generally decreased during the first year after heart transplantation. In vessels with donor-transmitted fibroatheroma, higher baseline lipid burden correlated with substantial lipid reduction and subsequent intimal volume proliferation.
- Open Access
On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases
This study introduces a novel method for evaluating red blood cell (RBC) deformability using a microfluidic platform equipped with constriction channels that mimic capillary vessels. The normalized transit velocity of RBCs at 50% compression ratio (V^ ε = 0.5 ) is proposed as a quantitative index of RBC deformability. Experimental validation is conducted in two key phases. First, to validate the proposed index, a controlled reduction in RBC deformability is induced using varying concentrations of diamide. V^ ε = 0.5 progressively decrease as the diamide concentration increased, confirming that the index tracks changes in RBC deformability. Second, to demonstrate the ability of the platform to detect disease‐specific properties, RBCs from patients with iron deficiency anemia (IDA), thalassemia (Thal), and hereditary spherocytosis (HS) are analyzed. The results reveal elevated deformability from IDA and Thal patients, and reduced deformability from HS patients. High V^ ε = 0.5 values consistently correlate with RBC characteristics known to enhance deformability—such as thin, elliptical morphology, a high surface‐area‐to‐volume ratio, and low internal viscosity—whereas lower values are associated with characteristics that impair deformability. These findings highlight the impact of RBC characteristics on deformability and the importance of our microfluidic platform as a robust tool for investigating hematological diseases.
Open AccessOn‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases
This study introduces a novel method for evaluating red blood cell (RBC) deformability using a microfluidic platform equipped with constriction channels that mimic capillary vessels. The normalized transit velocity of RBCs at 50% compression ratio (V^ ε = 0.5 ) is proposed as a quantitative index of RBC deformability. Experimental validation is conducted in two key phases. First, to validate the proposed index, a controlled reduction in RBC deformability is induced using varying concentrations of diamide. V^ ε = 0.5 progressively decrease as the diamide concentration increased, confirming that the index tracks changes in RBC deformability. Second, to demonstrate the ability of the platform to detect disease‐specific properties, RBCs from patients with iron deficiency anemia (IDA), thalassemia (Thal), and hereditary spherocytosis (HS) are analyzed. The results reveal elevated deformability from IDA and Thal patients, and reduced deformability from HS patients. High V^ ε = 0.5 values consistently correlate with RBC characteristics known to enhance deformability—such as thin, elliptical morphology, a high surface‐area‐to‐volume ratio, and low internal viscosity—whereas lower values are associated with characteristics that impair deformability. These findings highlight the impact of RBC characteristics on deformability and the importance of our microfluidic platform as a robust tool for investigating hematological diseases.
- Open Access
- 6 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
An on-chip deformability checker demonstrates that the severity of iron deficiency is associated with increased deformability of red blood cells
The deformability of red blood cells (RBCs) is essential for peripheral circulation and RBC survival and is reportedly altered in several diseases. However, its detail in iron-deficiency (ID) anemia remains poorly understood. We investigated the association between ID and RBC deformability in 120 participants classified into four groups according to their ferritin and hemoglobin levels: non-ID/non-anemia (n = 61), ID/non-anemia (n = 32), ID/anemia (n = 15), and non-ID/anemia (n = 12). In the analysis using the established on-chip deformability checker, the normalized transit velocity of RBCs through the peripheral-vessel constriction models was significantly higher in the ID/anemia group than in the other groups. The RBC deformability index (RDI), derived from the normalized transit velocity and degree of RBC deformation, was highest in the ID/anemia group, followed by the ID/non-anemia group. The RDI was negatively correlated with log10 ferritin levels (r = -0.66, p < 0.01), even after adjusting for hemoglobin levels. Lower log10 ferritin levels correlated with thinner, more oval-shaped RBCs and lower internal viscosity. These RBC characteristics were significantly associated with a higher RDI. These results suggest that, among several known determinants of RBC deformability, RBC morphology and internal viscosity are altered in ID, resulting in higher deformability.
- 6 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-9
Open AccessAn on-chip deformability checker demonstrates that the severity of iron deficiency is associated with increased deformability of red blood cells
The deformability of red blood cells (RBCs) is essential for peripheral circulation and RBC survival and is reportedly altered in several diseases. However, its detail in iron-deficiency (ID) anemia remains poorly understood. We investigated the association between ID and RBC deformability in 120 participants classified into four groups according to their ferritin and hemoglobin levels: non-ID/non-anemia (n = 61), ID/non-anemia (n = 32), ID/anemia (n = 15), and non-ID/anemia (n = 12). In the analysis using the established on-chip deformability checker, the normalized transit velocity of RBCs through the peripheral-vessel constriction models was significantly higher in the ID/anemia group than in the other groups. The RBC deformability index (RDI), derived from the normalized transit velocity and degree of RBC deformation, was highest in the ID/anemia group, followed by the ID/non-anemia group. The RDI was negatively correlated with log10 ferritin levels (r = -0.66, p < 0.01), even after adjusting for hemoglobin levels. Lower log10 ferritin levels correlated with thinner, more oval-shaped RBCs and lower internal viscosity. These RBC characteristics were significantly associated with a higher RDI. These results suggest that, among several known determinants of RBC deformability, RBC morphology and internal viscosity are altered in ID, resulting in higher deformability.
- Open Access
- 10 April 2025
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 7 (4) , 257-266
Machine-Learning-Based Prediction of Exercise Intolerance of Patients With Heart Failure Using Pragmatic Submaximal Exercise Parameters
Background: Low peak oxygen uptake (V̇O2), especially ≤14 mL/min/kg, is a strong indicator of poor prognosis in patients with heart failure (HF). However, measuring this parameter is sometimes difficult if the maximal workload is not reached. This study developed a predictive classification model for low peak V̇O2in HF patients using machine learning (ML).Methods and Results: We retrospectively analyzed the data for 343 patients with chronic HF and left ventricular ejection fraction <50% who underwent a symptom-limited cardiopulmonary exercise test and extracted 33 variables from their laboratory, echocardiographic, and exercise data up to the submaximal workload. The dataset was randomly divided into training and testing datasets in a 4 : 1 ratio. ML methods, including an exhaustive search for predictor selection, were used, and a support vector machine algorithm was applied for model optimization. We identified 5 important predictors: age, B-type natriuretic peptide, left ventricular end-diastolic diameter, V̇O2at rest, and V̇O2at respiratory exchange ratio of 1.00. Using these 5 predictors, an optimized predictive model was validated on the testing dataset, yielding an accuracy of 85%, F1 score of 0.81, and area under the receiver operating curve of 0.94 (95% confidence interval: 0.89–1.00).Conclusions: Using readily available parameters, ML methods can enable accurate prediction of low peak V̇O2in patients with HF.
- 10 April 2025
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 7 (4) , 257-266
Open AccessMachine-Learning-Based Prediction of Exercise Intolerance of Patients With Heart Failure Using Pragmatic Submaximal Exercise Parameters
Background: Low peak oxygen uptake (V̇O2), especially ≤14 mL/min/kg, is a strong indicator of poor prognosis in patients with heart failure (HF). However, measuring this parameter is sometimes difficult if the maximal workload is not reached. This study developed a predictive classification model for low peak V̇O2in HF patients using machine learning (ML).Methods and Results: We retrospectively analyzed the data for 343 patients with chronic HF and left ventricular ejection fraction <50% who underwent a symptom-limited cardiopulmonary exercise test and extracted 33 variables from their laboratory, echocardiographic, and exercise data up to the submaximal workload. The dataset was randomly divided into training and testing datasets in a 4 : 1 ratio. ML methods, including an exhaustive search for predictor selection, were used, and a support vector machine algorithm was applied for model optimization. We identified 5 important predictors: age, B-type natriuretic peptide, left ventricular end-diastolic diameter, V̇O2at rest, and V̇O2at respiratory exchange ratio of 1.00. Using these 5 predictors, an optimized predictive model was validated on the testing dataset, yielding an accuracy of 85%, F1 score of 0.81, and area under the receiver operating curve of 0.94 (95% confidence interval: 0.89–1.00).Conclusions: Using readily available parameters, ML methods can enable accurate prediction of low peak V̇O2in patients with HF.
- Open Access
- 2 March 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (4) , 2441-2449
Electron Microscopic Findings Predict Clinical Outcomes in Patients with Non-Ischaemic Cardiomyopathy
Aims: Electron microscopy reveals microstructural alterations in cardiomyocyte nuclei and myofilaments in non-ischaemic cardiomyopathy (NICM), particularly in dilated cardiomyopathy (DCM). Nevertheless, the correlation between such observations and clinical outcomes, including prognosis and left ventricular reverse remodelling (LVRR), remains unclear. This study aimed to examine the association between electron microscopic findings and outcomes in patients with NICM. Methods: In this multicentre, prospective, observational study, 170 patients with NICM with reduced ejection fraction (EF) < 40%, scheduled for diagnostic endomyocardial biopsy and optimization of medical therapies, were enrolled. Electron microscopic findings of cardiomyocytes such as discontinuous or continuous nuclear envelopes and injured or preserved myofilaments were evaluated. Data on cardiac events (cardiac death or left ventricular assist device implantation) and LVRR, defined as achieving an EF > 35% with a 10% unit absolute increase, were collected 1 year post-biopsy. Results: A total of 148 patients were finally analysed. Discontinuous nuclear envelopes and myofilament injuries were observed in 17 (11%) and 46 (31%) patients with NICM, respectively. The incidence of cardiac events at 1 year did not differ between groups with discontinuous and continuous nuclear envelopes [12% vs. 6%, odds ratio (OR): 2.05, 95% confidential interval (CI): 0.40–10.6, P = 0.391], whereas the LVRR rate was significantly lower in the discontinuous group than in the continuous group (24% vs. 52%, OR: 0.29, 95% CI: 0.08–0.92, P = 0.036). The incidences of cardiac events and LVRR at 1 year differed between the injured and preserved myofilament groups (15% vs. 3%, OR: 6.64, 95% CI: 1.32–33.5, P = 0.022; 15% vs. 64%, OR: 0.10, 95% CI: 0.04–0.25, P < 0.001, respectively). These associations between electron microscopic findings and clinical outcomes persisted, even in patients who were finally diagnosed with DCM. Conclusions: Discontinuous nuclear envelopes were associated with a reduced LVRR rate, whereas injured myofilaments were correlated with higher 1 year cardiac events and a decreased LVRR. Evaluation of electron microscopic images in diagnostic endomyocardial biopsy can facilitate risk stratification of NICM or DCM with reduced EF.
- 2 March 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (4) , 2441-2449
Open AccessElectron Microscopic Findings Predict Clinical Outcomes in Patients with Non-Ischaemic Cardiomyopathy
Aims: Electron microscopy reveals microstructural alterations in cardiomyocyte nuclei and myofilaments in non-ischaemic cardiomyopathy (NICM), particularly in dilated cardiomyopathy (DCM). Nevertheless, the correlation between such observations and clinical outcomes, including prognosis and left ventricular reverse remodelling (LVRR), remains unclear. This study aimed to examine the association between electron microscopic findings and outcomes in patients with NICM. Methods: In this multicentre, prospective, observational study, 170 patients with NICM with reduced ejection fraction (EF) < 40%, scheduled for diagnostic endomyocardial biopsy and optimization of medical therapies, were enrolled. Electron microscopic findings of cardiomyocytes such as discontinuous or continuous nuclear envelopes and injured or preserved myofilaments were evaluated. Data on cardiac events (cardiac death or left ventricular assist device implantation) and LVRR, defined as achieving an EF > 35% with a 10% unit absolute increase, were collected 1 year post-biopsy. Results: A total of 148 patients were finally analysed. Discontinuous nuclear envelopes and myofilament injuries were observed in 17 (11%) and 46 (31%) patients with NICM, respectively. The incidence of cardiac events at 1 year did not differ between groups with discontinuous and continuous nuclear envelopes [12% vs. 6%, odds ratio (OR): 2.05, 95% confidential interval (CI): 0.40–10.6, P = 0.391], whereas the LVRR rate was significantly lower in the discontinuous group than in the continuous group (24% vs. 52%, OR: 0.29, 95% CI: 0.08–0.92, P = 0.036). The incidences of cardiac events and LVRR at 1 year differed between the injured and preserved myofilament groups (15% vs. 3%, OR: 6.64, 95% CI: 1.32–33.5, P = 0.022; 15% vs. 64%, OR: 0.10, 95% CI: 0.04–0.25, P < 0.001, respectively). These associations between electron microscopic findings and clinical outcomes persisted, even in patients who were finally diagnosed with DCM. Conclusions: Discontinuous nuclear envelopes were associated with a reduced LVRR rate, whereas injured myofilaments were correlated with higher 1 year cardiac events and a decreased LVRR. Evaluation of electron microscopic images in diagnostic endomyocardial biopsy can facilitate risk stratification of NICM or DCM with reduced EF.
- Open Access
- 23 January 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1504031
Energy intake insufficiency due to underestimated energy requirement by common predictive formulas can be identified by urinary amino acid levels in advanced heart failure
Background: Elevated resting energy expenditure (REE) promotes cachexia, worsening prognosis in patients with advanced heart failure (HF). However, adequate assessment of energy balance is challenging because of unvalidated common prediction methods and unestablished determinants of REE, resulting in a lack of biomarkers for predicting insufficient energy intake.Objective: This cross-sectional study aimed to evaluate REE in patients with advanced HF and explore biomarkers for insufficient energy intake.Methods: We measured REE by indirect calorimetry and calculated the total energy expenditure (TEE) of 72 hospitalized patients with advanced-stage HF. We compared these values with commonly-used formulas and analyzed the associations between REE per body weight (REEBW) and parameters related to hemodynamics and HF severity. In 17 of 72 patients, plasma amino acid (AA) and 24-h urinary AA concentrations were measured to analyze their correlations with energy balance, the ratio of caloric intake to REE.Results: Resting energy expenditure and TEE values were significantly higher than the predicted values. The mean REEBW was 25 kcal/kg/day, while that for the underweight (2) was 28 kcal/kg/day. We found a significant negative correlation between REEBW and body mass index (BMI), but no significant correlation between REEBW and HF-related parameters. The difference between TEE and predicted TEE using the European Society for Clinical Nutrition and Metabolism formula was most significant in the underweight patients because of underestimation, whereas TEE and pTEE using our modified formula with coefficients by BMI categories did not differ. There was a significant correlation between energy balance and urinary histidine and its metabolite 3-methylhistidine excretion, but no significant correlation with serum albumin and other AA concentrations.Conclusion: Underweight patients with advanced HF require more energy per weight than the predicted value. Our proposed formula for pTEE in each BMI category may be useful in clinical practice to avoid underestimation of daily energy requirements. Inadequate energy intake, even with such an approach, may be identified by decreased urinary essential AA levels.
- 23 January 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1504031
Open AccessEnergy intake insufficiency due to underestimated energy requirement by common predictive formulas can be identified by urinary amino acid levels in advanced heart failure
Background: Elevated resting energy expenditure (REE) promotes cachexia, worsening prognosis in patients with advanced heart failure (HF). However, adequate assessment of energy balance is challenging because of unvalidated common prediction methods and unestablished determinants of REE, resulting in a lack of biomarkers for predicting insufficient energy intake.Objective: This cross-sectional study aimed to evaluate REE in patients with advanced HF and explore biomarkers for insufficient energy intake.Methods: We measured REE by indirect calorimetry and calculated the total energy expenditure (TEE) of 72 hospitalized patients with advanced-stage HF. We compared these values with commonly-used formulas and analyzed the associations between REE per body weight (REEBW) and parameters related to hemodynamics and HF severity. In 17 of 72 patients, plasma amino acid (AA) and 24-h urinary AA concentrations were measured to analyze their correlations with energy balance, the ratio of caloric intake to REE.Results: Resting energy expenditure and TEE values were significantly higher than the predicted values. The mean REEBW was 25 kcal/kg/day, while that for the underweight (2) was 28 kcal/kg/day. We found a significant negative correlation between REEBW and body mass index (BMI), but no significant correlation between REEBW and HF-related parameters. The difference between TEE and predicted TEE using the European Society for Clinical Nutrition and Metabolism formula was most significant in the underweight patients because of underestimation, whereas TEE and pTEE using our modified formula with coefficients by BMI categories did not differ. There was a significant correlation between energy balance and urinary histidine and its metabolite 3-methylhistidine excretion, but no significant correlation with serum albumin and other AA concentrations.Conclusion: Underweight patients with advanced HF require more energy per weight than the predicted value. Our proposed formula for pTEE in each BMI category may be useful in clinical practice to avoid underestimation of daily energy requirements. Inadequate energy intake, even with such an approach, may be identified by decreased urinary essential AA levels.
- Open Access
- 24 September 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 418, 132596
Ratio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation
- 24 September 2024
- Published by Elsevier in International Journal of Cardiology
- Vol. 418, 132596
Open AccessRatio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation